See some of the latest developments, discoveries and commentaries from the WashU Medicine Department of Obstetrics and Gynecology.
For more news and updates:
Follow us on Twitter »
Listen to our Podcast »
Subscribe to our newsletter »
Media contact:
Jessica Church, Director of Media Relations – WashU Medicine Marketing & Communications
j.church@wustl.edu
ObGyn Rocks: “Leading From Where We Are” – Dr. Dineo Khabele (Links to an external site)
R21 grant for labor research
Antonina Frolova, MD, PhD, Assistant Professor of Obstetrics and Gynecology, was awarded an R21 for her project titled, “Metabolic mechanisms of uterine contractility in labor.” The objective of the project is to determine the mechanisms driving obesity-related labor dysfunction. This research may lead to new options for pharmacologic and behavioral interventions to optimize myometrial energy […]
$11.6 million grant supports innovative research in endometrial cancer (Links to an external site)
Cases of endometrial cancer — a gynecologic cancer of the lining of the uterus — have increased in recent decades, as have deaths caused by the condition. To spur new strategies to prevent and treat endometrial cancer, the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded researchers at Washington University […]
R01 grant for research on maternal opioid use
Jeannie Kelly, MD, MS, Associate Professor of Obstetrics and Gynecology, and Yong Wang, PhD, Professor of Obstetrics and Gynecology, were awarded an R01 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The project is titled, “The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta […]
Dr. Mullen receives 2023 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award
Dr. Maggie Mullen has been awarded grant funding through the 2023 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in partnership with Pelotonia & AACR, Targeting platinum chemotherapy resistance in ovarian cancer. **This two-year grant starts in September.** These accomplishments are impossible without our amazing research and clinical teams and the sponsorship of our […]